Akero Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2018 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Akero Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2018 to Q3 2024.
  • Akero Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 69.6M shares, a 25% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 69.6M +13.9M +25% Sep 30, 2024 10-Q 2024-11-08
Q2 2024 69.2M +13.7M +24.6% Jun 30, 2024 10-Q 2024-08-09
Q1 2024 69.1M +22.2M +47.2% Mar 31, 2024 10-Q 2024-05-10
Q4 2023 55.8M +8.89M +19% Dec 31, 2023 10-Q 2024-11-08
Q3 2023 55.7M +9.02M +19.3% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 55.5M +18M +47.9% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 47M +12M +34.1% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 46.9M +12M +34.3% Dec 31, 2022 10-K 2024-02-29
Q3 2022 46.7M +11.8M +33.8% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 37.6M +2.73M +7.83% Jun 30, 2022 10-Q 2022-08-05
Q1 2022 35M +253K +0.73% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 34.9M +159K +0.46% Dec 31, 2021 10-K 2023-03-17
Q3 2021 34.9M +155K +0.45% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 34.8M +6.16M +21.5% Jun 30, 2021 10-Q 2021-08-13
Q1 2021 34.8M +6.1M +21.3% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 34.7M +6.17M +21.6% Dec 31, 2020 10-K 2022-02-25
Q3 2020 34.7M +6.16M +21.6% Sep 30, 2020 10-Q 2020-11-12
Q2 2020 28.7M +128K +0.45% Jun 30, 2020 10-Q 2020-08-12
Q1 2020 28.7M Mar 31, 2020 10-Q 2020-05-13
Q4 2019 28.6M +28.3M +11854% Dec 31, 2019 10-K 2021-03-16
Q3 2019 28.6M Sep 30, 2019 10-Q 2019-11-12
Q2 2019 28.6M Jun 30, 2019 10-Q 2019-08-12
Q4 2018 239K Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.